Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 50.14 K185.05 K200.99 K216.92 K324.04 K1.28 M 2.02 M Research & development —————— — Operating income -50.14 K-185.05 K-200.99 K-216.92 K-324.04 K-1.28 M -2.02 M Non-Operating Income, Total 0993.36 K1.56 M1.47 M1.35 M1.36 M 5.75 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 000000 0 Unusual income/expense 0993.36 K1.56 M1.47 M1.35 M1.36 M 5.75 M Pretax income -50.14 K808.31 K1.36 M1.26 M1.03 M87.4 K 3.73 M Equity in earnings —————— — Taxes 000000 0 Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -50.14 K808.31 K1.36 M1.26 M1.03 M87.4 K 3.73 M Discontinued operations —————— — Net income -50.14 K808.31 K1.36 M1.26 M1.03 M87.4 K 3.73 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -50.14 K808.31 K1.36 M1.26 M1.03 M87.4 K 3.73 M Basic earnings per share (Basic EPS) 0.040.150.160.120.10.12 — Diluted earnings per share (Diluted EPS) 0.040.150.160.120.10.12 — Average basic shares outstanding 5 M9.95 M13.28 M15.14 M20.5 M20.5 M — Diluted shares outstanding -23.23 M9.95 M13.28 M15.14 M20.5 M20.5 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —